One of the most commonly observed adverse effects of cyclosporin A (CsA) is the development of gingival overgrowth (GO). Fibroblasts are involved in GO, but the question why only a percentage of patients undergoing CsA treatment shows this side-effect remains unanswered. In a previous study, CsA has been demonstrated to induce over-expression of phospholipase C (PLC) beta(1) in fibroblasts of patients with clinical GO, in cells from both enlarged and clinically healthy gingival sites. In this work, we assessed the expression of PLC beta isoforms to investigate whether the exaggerated fibroblast response to CsA related to increased PLC beta(1) expression could also be detected in CsA-treated patients without clinical signs of GO. Our results support the hypothesis of a multi-factorial origin of gingival overgrowth, including specific changes within the gingival tissues orchestrating fibroblastic hyper-responsiveness as a consequence of a long-term in vivo exposure to cyclosporin A.

Ruggeri A Jr., Montebugnoli L., Matteucci A., Zini N., Solimando L., Servidio D., et al. (2005). Cyclosporin A Specifically Affects Nuclear PLC{beta}1 in Immunodepressed Heart Transplant Patients with Gingival Overgrowth. JOURNAL OF DENTAL RESEARCH, 84(8), 747-751.

Cyclosporin A Specifically Affects Nuclear PLC{beta}1 in Immunodepressed Heart Transplant Patients with Gingival Overgrowth

RUGGERI, ALESSANDRA;MONTEBUGNOLI, LUCIO;SOLIMANDO, LILIANA;SERVIDIO, DORA;SUPPA, PIETRO;COCCO, LUCIO ILDEBRANDO;BRESCHI, LORENZO
2005

Abstract

One of the most commonly observed adverse effects of cyclosporin A (CsA) is the development of gingival overgrowth (GO). Fibroblasts are involved in GO, but the question why only a percentage of patients undergoing CsA treatment shows this side-effect remains unanswered. In a previous study, CsA has been demonstrated to induce over-expression of phospholipase C (PLC) beta(1) in fibroblasts of patients with clinical GO, in cells from both enlarged and clinically healthy gingival sites. In this work, we assessed the expression of PLC beta isoforms to investigate whether the exaggerated fibroblast response to CsA related to increased PLC beta(1) expression could also be detected in CsA-treated patients without clinical signs of GO. Our results support the hypothesis of a multi-factorial origin of gingival overgrowth, including specific changes within the gingival tissues orchestrating fibroblastic hyper-responsiveness as a consequence of a long-term in vivo exposure to cyclosporin A.
2005
Ruggeri A Jr., Montebugnoli L., Matteucci A., Zini N., Solimando L., Servidio D., et al. (2005). Cyclosporin A Specifically Affects Nuclear PLC{beta}1 in Immunodepressed Heart Transplant Patients with Gingival Overgrowth. JOURNAL OF DENTAL RESEARCH, 84(8), 747-751.
Ruggeri A Jr.; Montebugnoli L.; Matteucci A.; Zini N.; Solimando L.; Servidio D.; Suppa P.; Cadenaro M.; Cocco L.; Breschi L.
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/5576
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 1
social impact